Well that's all very well, but your analysis seems to completely disregard the aspect of time on therapy in having a therapeutic effect. I seem to remember in an earlier post you denigrated the trial because it was funded by Imugene, and therefore not credible. But the peer review comes later, after the trial results, and they wouldn't conduct it in any way other then to ensure successful peer review. It's how science is done
Well that's all very well, but your analysis seems to completely...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $537.6K | 10.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 207796 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1452903 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |